Trent G. Kamke - Dec 19, 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Senior V. P., Operations
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Dec 19, 2022
Transactions value $
-$5,754
Form type
4
Date filed
12/21/2022, 08:18 PM
Previous filing
Dec 13, 2022
Next filing
Dec 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +2 +0.02% $0.00 10.2K Dec 19, 2022 Direct F1
transaction LMAT Common Stock Tax liability -$3.38K -74 -0.72% $45.74 10.1K Dec 19, 2022 Direct F2
transaction LMAT Common Stock Options Exercise $0 +3 +0.03% $0.00 10.1K Dec 20, 2022 Direct F1
transaction LMAT Common Stock Tax liability -$2.37K -51 -0.5% $46.46 10.1K Dec 20, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -2 -21.48% $0.00 7.31 Dec 19, 2022 Common Stock 2 Direct F4
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -3 -29.1% $0.00 7.31 Dec 20, 2022 Common Stock 3 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.